gsidgsidgsid
Welcome to the Global Solutions For Infectious Diseases Website
GSID Home Page
About Us
Our Programs
Support GSID
News & Presentations
Contact Us
header

Dengue Vaccine Development

GSID’s expertise in clinical and product development has been utilized by the Pediatric Dengue Vaccine Initiative (PDVI), a program of the International Vaccine Institute in Seoul, Korea. We have been evaluating candidate vaccines, their respective developers and potential manufacturing partners around the world. Our evaluations of development partners have provided PDVI with the necessary input to further the advancement of evaluating dengue vaccines in large-scale trials. We have also been working closely with the Butantan Institute (Sao Paolo, Brazil) on their dengue vaccine development program.

About Dengue

Dengue fever is a mosquito-borne disease, primarily of children, and prevalent in tropical countries around the world. Dengue fever has severe consequences of hemorrhagic fever and dengue shock and results in substantial morbidity and mortality. There is currently no vaccine available for dengue, although a number of vaccine candidates are in various stages of development. For more information please see:

CDC Dengue Fever Fact Sheet
WHO Dengue page

© 2009 Global Solutions for Infectious Diseases, All Rights Reserved


TIME honors our HIV vaccine as #2 Medical Breakthrough and #8 Innovation of the Year [more]